Shuchi Nahar's Weekend Blog!

Ultimate Guide to CRAMS or CDMO  with various Companies to track Twitter Handle: @shuchi_nahar What are CRAMS? CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: Contract Research and Contract Manufacturing . CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future. Roadmap Ahead Investments in the global pharmaceuticals sector to increase to over $1,400 billion over the next 3 years, driven by a number of new medicines. With healthy R&D spending going forward, the Contract Research and Manufacturing (CRAMS) segment offers growth opportunities to Indian companies. Rising demand for generic formulati

Sequent Scientific Limited - Company Overview Twitter Handle: @s huchi_nahar Link to Animal Healthcare Related Articles: https://myweekendspot.blogspot.com/2020/08/animal-health-care-industry-future-ahead.html 1) Company Profile Incorporated in 1985, Sequent Scientific Ltd (SSL) undertakes its animal health business under the aegis of Alivira Animal Health Limited, which is engaged in manufacturing veterinary APIs and formulations. Earlier SSL was engaged in the manufacturing human APIs, which has been de-merged with effect from October, 2017. Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF). Sequent is India’s first integrated, global animal health company with an annual revenue run-rate of US$ 150 million. It offers API, branded generic formulations and analytical services. Over the past four years, compa

  Syngene International Limited -  Company Overview Twitter Handle: @shuchi_nahar Link to FY 2020-21 Annual Report takeaways - https://myweekendspot.blogspot.com/2021/10/syngene-international-ltd-fy2020-21.html 1. Company Overview Incorporated in 1994 as a subsidiary of Biocon, Syngene International (SIL) is a leading contract research organization (CRO), which supports R&D programs of global innovative companies   SIL offers outsourced services to support discovery and development for organizations across industrial sectors like pharmaceuticals, biopharmaceuticals, nutraceuticals, animal health, agro-chemicals, etc. It currently caters to 293 global players including Bristol-Myers Squibb (BMS), Abbott, Baxter and Amgen, among others. SIL derives 95% of its revenues from exports. Mangalore API plant is constructed and validation is expected to be completed in FY21.  In FY20, Syngene extended its biologics discovery and preclinical research capabilities in CAR-T therapy,